Trade receivables decreased 40.5%
Trade receivables changed -40.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables changed -40.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed -59.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +91.3% from the comparable as-filed period.
Working capital / assets changed +1261 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +30.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed -50.7% from the comparable as-filed period.
Operating margin changed +2856 basis points from the comparable as-filed period.
Net income changed +91.7% from the comparable as-filed period.
Research & development changed -74.2% from the comparable as-filed period.
Gross margin changed -1170 basis points from the comparable as-filed period.
Working capital changed +168.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Free-cash-flow proxy changed +153.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed -43.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -70.6% from the comparable as-filed period.
Cost of revenue changed -33.6% from the comparable as-filed period.
Current assets changed -46.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed -59.4% from the comparable as-filed period.
Operating cash flow changed +307.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +21.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -49.4% from the comparable as-filed period.
SBC / revenue changed -304 basis points from the comparable as-filed period.
Free-cash-flow margin changed +2382 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +2400 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -1305 basis points from the comparable as-filed period.
Receivables / revenue changed +353 basis points from the comparable as-filed period.
Shares outstanding changed +2.5% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Capex / revenue changed +18 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.